80 related articles for article (PubMed ID: 19918658)
1. [Quality and performance of pap smears in the cervical cancer screening program in a city of southern Brazil].
Uchimura NS; Nakano K; Nakano LC; Uchimura TT
Rev Assoc Med Bras (1992); 2009; 55(5):569-74. PubMed ID: 19918658
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
3. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
4. Coverage and focus of a cervical cancer prevention program in southern Brazil.
de Quadros CA; Victora CG; da Costa JS
Rev Panam Salud Publica; 2004 Oct; 16(4):223-32. PubMed ID: 15615596
[TBL] [Abstract][Full Text] [Related]
5. The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index.
Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
Cancer Prev Res (Phila); 2020 Mar; 13(3):299-308. PubMed ID: 31836602
[TBL] [Abstract][Full Text] [Related]
6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
7. [Pap smear coverage and factors associated with non-participation in cervical cancer screening: an analysis of the Cervical Cancer Prevention Program in Pernambuco State, Brazil].
Albuquerque KM; Frias PG; Andrade CL; Aquino EM; Menezes G; Szwarcwald CL
Cad Saude Publica; 2009; 25 Suppl 2():S301-9. PubMed ID: 19684937
[TBL] [Abstract][Full Text] [Related]
8. Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait.
Luthra UK; Chishti M; Dey P; Jolly SV; Abdulla M; Das DK; Sugathan TN; Ajrawi MT; George J; George SS; Aziz AA; al-Juwaiser A; Karim FA; Mallik MK; Sheikh ZA; Khan S
Acta Cytol; 2002; 46(2):303-10. PubMed ID: 11917577
[TBL] [Abstract][Full Text] [Related]
9. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection.
Ronnett BM; Manos MM; Ransley JE; Fetterman BJ; Kinney WK; Hurley LB; Ngai JS; Kurman RJ; Sherman ME
Hum Pathol; 1999 Jul; 30(7):816-25. PubMed ID: 10414501
[TBL] [Abstract][Full Text] [Related]
10. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
12. Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative.
Polanco Jacome EC; Maerki J; Chau K; Akerman M; Sajjan S; Klein M; Gimenez C; Laser A; Das K
Diagn Cytopathol; 2018 Jul; 46(7):584-588. PubMed ID: 29722175
[TBL] [Abstract][Full Text] [Related]
13. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
[TBL] [Abstract][Full Text] [Related]
14. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
[TBL] [Abstract][Full Text] [Related]
15. Population-based cervical screening outcomes in Turkey over a period of approximately nine and a half years with emphasis on results for women aged 30-34.
Sengul D; Altinay S; Oksuz H; Demirturk H; Korkmazer E
Asian Pac J Cancer Prev; 2014; 15(5):2069-74. PubMed ID: 24716936
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer screening coverage and associated factors in a city in southern Brazil: a population-based study].
Gasperin SI; Boing AF; Kupek E
Cad Saude Publica; 2011 Jul; 27(7):1312-22. PubMed ID: 21808816
[TBL] [Abstract][Full Text] [Related]
17. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
18. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization.
Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O
Acta Cytol; 2012; 56(3):251-8. PubMed ID: 22555526
[TBL] [Abstract][Full Text] [Related]
19. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
20. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
